Correction to: Diabetol Metab Syndr (2018) 10:8 10.1186/s13098-018-0309-6
It has been highlighted that the original article [1], published 21 February 2018, contained some errors in Table 3. This correction article shows the correct version of Table 3 and the changes that were made.
Table 3.
The prevalence of peripheral neuropathy among patients with type 2 diabetes mellitus in Jordan according to relevant socio-demographic, clinical and laboratory characteristics
| Variables | Peripheral neuropathy | P value | |
|---|---|---|---|
| Yes n = 396 |
No n = 607 |
||
| Gender | 0.137 | ||
| Male | 201 (41.9) | 279 (58.1) | |
| Female | 195 (37.3) | 328 (62.7) | |
| Age (year) | < 0.001 | ||
| < 50 | 23 (17.4) | 109 (82.6) | |
| 50–69 | 269 (38.9) | 423 (61.1) | |
| ≥ 70 | 104 (58.1) | 75 (41.9) | |
| Marital status | 0.777 | ||
| Single/divorced/widowed | 52 (40.6) | 76 (59.4) | |
| Married | 344 (39.3) | 531 (60.7) | |
| Working status | < 0.001 | ||
| Unemployed | 175 (50.9) | 169 (49.1) | |
| Employed | 83 (29.6) | 197 (70.4) | |
| Retired | 138 (36.4) | 241 (63.6) | |
| Physical activity | < 0.001 | ||
| Regular | 29 (31.5) | 63 (68.5) | |
| Not regular | 72 (25) | 216 (75) | |
| No physical activity | 295 (47.4) | 328 (52.6) | |
| Family history of diabetes | 0.014 | ||
| Present | 356 (41) | 513(59) | |
| Absent | 40 (29.9) | 94 (70.1) | |
| Regular visit to treating physicians | < 0.001 | ||
| Yes | 342 (37.3) | 575 (62.7) | |
| No | 54 (62.8) | 32 (37.2) | |
| Body mass index (kg/m2) | 0.052 | ||
| Normal | 32 (37.6) | 53 (62.4) | |
| Over weight | 103 (34.1) | 199 (65.9) | |
| Obese | 261 (42.4) | 355 (57.6) | |
| Duration of diabetes (year) | < 0.001 | ||
| < 5 | 29 (8.7) | 304 (91.3) | |
| 5–11 | 139 (39) | 217 (61) | |
| ≥ 12 | 288 (72.6) | 86 (27.4) | |
| Having hypertension | < 0.001 | ||
| Yes | 374 (43.5) | 486 (56.5) | |
| No | 22 (15.4) | 121 (84.6) | |
| Nephropathy | < 0.001 | ||
| Yes | 65 (69.1) | 29 (30.9) | |
| No | 331 (36.4) | 578 (63.6) | |
| Cardiovascular disease | < 0.001 | ||
| Yes | 210 (54.8) | 173 (45.2) | |
| No | 186 (30) | 434 (70) | |
| Dyslipidemia | < 0.001 | ||
| Yes | 381 (43) | 505 (57) | |
| No | 15 (12.8) | 102 (87.2) | |
| Retinopathy | < 0.001 | ||
| Yes | 132 (67.3) | 64 (32.7) | |
| No | 264 (32.7) | 543 (67.3) | |
| Type of treatment | < 0.001 | ||
| Insulin only | 77 (60.2) | 51 (39.8) | |
| Oral hypoglycemia agents only | 120 (22.8) | 407 (77.2) | |
| Oral hypoglycemia agents and insulin | 199 (57.2) | 149 (42.8) | |
| HbA1c (%) | < 0.001 | ||
| Controlled < 7% | 96 (22.7) | 326 (77.3) | |
| Uncontrolled ≥ 7% | 300 (51.6) | 281 (48.4) | |
Changes:
A labeling error in Table 3 was corrected (Neuropathy status was replaced by Peripheral neuropathy).
[Without DPN n = 607 (100%)] was replaced by (Yes n = 396).
[With DPN n = 396 (100%)] was replaced by (No n = 607).
[Age group (year): (mean ± SD)] was replaced by [Age (year)], and the mean age was removed from the table.
[Body mass index (BMI) (kg/m2): (mean ± SD)] was replaced by [Body mass index (kg/m2)] and the mean BMI was removed.
[Duration of diabetes (year): (mean ± SD)] was replaced by [Duration of diabetes (year)] and the mean duration was removed.
SBP mmHg (mean ± SD) DBP mmHg (mean ± SD) was removed.
All these were removed TC (mean ± SD), LDL (mean ± SD), HDL (mean ± SD).
[HbA1C (%): (mean ± SD)] was replaced by [HbA1c (%)], and the mean HbA1c was removed from the table.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Footnotes
The original article can be found online at 10.1186/s13098-018-0309-6.
Reference
- 1.Khawaja N, Abu-Shennar J, Saleh M, Dahbour SS, Khader YS, Ajlouni KM. The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetol Metab Syndr. 2018;10:8. doi: 10.1186/s13098-018-0309-6. [DOI] [PMC free article] [PubMed] [Google Scholar]